Claims
- 1. An ether compound of the general formula: ##STR98## wherein R.sup.1 is halogen; A is any of the groups of the following formulas Q-1 to Q-11: ##STR99## R.sup.2, R.sup.3, R.sup.4 and R.sup.7 are independently hydrogen or methyl;
- R.sup.5 and R.sup.8 are independently C.sub.1 -C.sub.4 alkyl (optionally substituted with halogen or methoxy), C.sub.3 -C.sub.4 alkenyl (optionally substituted with halogen) or C.sub.3 -C.sub.4 alkynyl (optionally substituted with halogen);
- R.sup.6 is a group represented by R.sup.5, or hydrogen;
- R.sup.9 is halogen or C.sub.1 -C.sub.4 alkyl (optionally substituted with halogen);
- R.sup.10 and R.sup.11 are independently hydrogen, C.sub.1 -C.sub.4 alkyl or C.sub.3 -C.sub.4 alkenyl;
- B is a group of the general formula: ##STR100## E is a group of the general formula: ##STR101## R.sup.12 is halogen, or methyl optionally substituted with halogen; X and Y are independently oxygen or sulfur;
- W is oxygen, sulfur or NH; and
- l, m and n are independently an integer of 0 to 2.
- 2. An ether compound according to claim 1, wherein E is a group of the general formula: ##STR102## wherein R.sup.12 and n are as defined above.
- 3. An ether compound according to claim 2, wherein n is 0.
- 4. An ether compound according to claim 1, wherein A is a group represented by Q-1, Q-2, Q-3, Q-5 or Q-10.
- 5. An ether compound according to claim I, wherein A is a group represented by Q-1, Q-2, Q-3, Q-5 or Q-10; R.sup.2, R.sup.3 and R.sup.4 are all hydrogen; and m is 0.
- 6. 2-�4-(1-Pyrazolyl)methylphenoxy!ethylcarbamic acid methyl ester.
- 7. 1-{3-�4-(1-Pyrazolyl)methylphenoxy!propyl}pyrazole.
- 8. N-{2-�4-(1-Pyrazolyl)methylphenoxy!ethyl}cyclopropanecarboxide.
- 9. 4-�4-(1-Pyrazolyl)methylphenoxy!methyl-2-ethyl-1,3-dioxolane.
- 10. A harmful-organism controlling agent characterized by comprising as an active ingredient an ether compound according to claim 1.
- 11. An phenol compound of the general formula: ##STR103## wherein E is a group of the general formula: ##STR104## R.sup.12 is halogen, or methyl optionally substituted with halogen; and n is an integer of 0 to 2.
Priority Claims (1)
Number |
Date |
Country |
Kind |
6-070496 |
Apr 1994 |
JPX |
|
Parent Case Info
This application is a 371 of PCT/JP95/00664 filed Apr. 6, 1995.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/JP95/00664 |
4/6/1995 |
|
|
12/12/1996 |
12/12/1996 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO95/27700 |
10/19/1995 |
|
|
US Referenced Citations (9)
Foreign Referenced Citations (7)
Number |
Date |
Country |
0 530 702 A1 |
Aug 1992 |
EPX |
2 008 677 |
Sep 1971 |
DEX |
27 45 833 |
Apr 1979 |
DEX |
30 25 219 A1 |
Jan 1982 |
DEX |
1 330 059 |
Sep 1973 |
GBX |
1 592 516 |
Jul 1981 |
GBX |
9214714 |
Sep 1992 |
WOX |